We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

141 hedge funds and large institutions have $1.69B invested in Adverum Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 38 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more call options, than puts

Call options by funds: $15.9M | Put options by funds: $5.1M

114% more capital invested

Capital invested by funds: $790M → $1.69B (+$899M)

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

58% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 38

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

12% more funds holding

Funds holding: 126 → 141 (+15)

0.07% less ownership

Funds ownership: 10.14% → 10.07% (-0.07%)

Holders
141
Holders Change
+15
Holders Change %
+11.9%
% of All Funds
2.89%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
29
Increased
60
Reduced
38
Closed
14
Calls
$15.9M
Puts
$5.1M
Net Calls
+$10.8M
Net Calls Change
-$273K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$22M
2
BlackRock
BlackRock
New York
+$15.3M
3
CC
Casdin Capital
New York
+$13.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.8M
5
RCM
RA Capital Management
Massachusetts
+$9.37M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$25.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$23M
3
DM
Deerfield Management
New York
-$22M
4
UBS Group
UBS Group
Switzerland
-$14.4M
5
VA
VR Adviser
New York
-$9.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$163M +$9.37M +52,893 +7%
ACA
2
Avoro Capital Advisors
New York
$158M +$7.7M +43,500 +6%
VVM
3
Versant Venture Management
California
$146M -$1.14M -6,434 -0.9%
RI
4
RTW Investments
New York
$142M +$2.81M +15,840 +2%
BlackRock
5
BlackRock
New York
$123M +$15.3M +86,615 +17%
SFI
6
Sonic Fund II
Hawaii
$85.9M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$80.3M +$11.8M +66,817 +21%
State Street
8
State Street
Massachusetts
$72.6M +$2.36M +13,303 +4%
O
9
OrbiMed
New York
$68.7M -$2.83M -15,990 -5%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$44.4M -$5.82M -32,872 -13%
CC
11
Casdin Capital
New York
$38.9M +$13.1M +74,000 +66%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$38.9M -$262K -1,478 -0.8%
ACP
13
Acuta Capital Partners
California
$36.5M +$744K +4,200 +2%
UBS Group
14
UBS Group
Switzerland
$34.7M -$14.4M -81,158 -33%
FM
15
Frazier Management
Washington
$30M +$2.81M +15,870 +12%
Wellington Management Group
16
Wellington Management Group
Massachusetts
$25.9M +$22M +123,936 New
Goldman Sachs
17
Goldman Sachs
New York
$23.8M +$4.12M +23,282 +26%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$21.9M +$2.44M +13,761 +15%
Northern Trust
19
Northern Trust
Illinois
$19.8M +$2.62M +14,776 +18%
GTC
20
Ghost Tree Capital
New York
$18.8M -$7.18M -40,550 -31%
AG
21
Artal Group
Luxembourg
$18.8M +$5.31M +30,000 +50%
Citadel Advisors
22
Citadel Advisors
Florida
$18M -$4.94M -27,891 -24%
DM
23
Deerfield Management
New York
$17.4M -$22M -124,110 -60%
UBS AM
24
UBS AM
Illinois
$16.1M +$266K +1,500 +2%
WM
25
WS Management
Florida
$14.7M -$2.02M -11,395 -14%
1
2 3 4 5

ADVM Hedge Fund Activity: Q2 2020 in Review

141 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2020, worth a combined $1.69B — up 114% from $790M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ADVM positions and 14 closed out — a net gain of 15 holders — while 60 added to existing stakes and 38 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $22M. The largest seller was Victory Capital Management, cutting an estimated $25.8M.

  • 141 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2020, up from 126 in Q1 2020.
  • Funds reported $1.69B of Adverum Biotechnologies stock for Q2 2020, up 114% quarter-over-quarter.
  • 29 funds opened new Adverum Biotechnologies positions in Q2 2020 and 14 closed out, a net change of +15 holders.
  • The largest Adverum Biotechnologies buyer in Q2 2020 was Wellington Management Group, an estimated $22M added.
  • The largest Adverum Biotechnologies seller in Q2 2020 was Victory Capital Management, an estimated $25.8M sold.

Based on aggregated 13F filings for Q2 2020.